Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
This study has been terminated.
( After review of safety events and have decided that further dose escalation of MEDI-507 as a single agent is not feasible. )
Study NCT00105313   Information provided by MedImmune LLC

First Received on March 11, 2005.   Last Updated on June 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial